Island Pharmaceuticals Limited ACN 641 183 842 | Registered office: Level 1 Suite 1, 117 Camberwell Road, Hawthorn East VIC 3123 Australia Page 1 of 2 13 August 2026 ASX Announcement DATE OF ANNUAL GENERAL MEETING AND CLOSING DATE FOR DIRECTOR NOMINATIONS ...
Date of AGM & Closing Date for Director Nominations
Filed with ASX · · 2 pages · English
Release
Island Pharmaceuticals Ltd on 6ix
Earlier from Island Pharmaceuticals
- Cleansing Notice
- Application for quotation of securities - ILA
- Investor presentation
- Quarterly Appendix 4C and Activities Report
- Texas Biomed SOW accelerates pivotal FDA pathway
Later from Island Pharmaceuticals
- Island boosts Galidesivir supply as Ebola surges
- Preliminary Final Report
- Annual Report to shareholders
- Appendix 4G and Corporate Governance Statement
- Pivotal Marburg data secured for Galidesivir FDA pathway
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals